<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Simoes Cunha M</submitter><funding>Foundation for Science and Technology</funding><pagination>e068725</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10163458</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(5)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Anxiety and depression are relevant comorbidities in asthma, but, in Portugal and Spain, data on this topic are scarce. We assessed, in patients with asthma, the frequency of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and the European Quality of Life Five Dimension Questionnaire (EQ-5D); the level of agreement between these questionnaires, and the factors associated with these symptoms.&lt;h4>Methods&lt;/h4>This is a secondary analysis of the INSPIRERS studies. A total of 614 adolescents and adults with persistent asthma (32.6±16.9 years, 64.7% female) were recruited from 30 primary care centres and 32 allergy, pulmonology and paediatric clinics. Demographic and clinical characteristics, HADS and EQ-5D were collected. A score ≥8 on Hospital A</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.</pubmed_title><pmcid>PMC10163458</pmcid><funding_grant_id>PTDC/MEC-OUT/29130/2017</funding_grant_id><pubmed_authors>Camara R</pubmed_authors><pubmed_authors>Alves-Correia M</pubmed_authors><pubmed_authors>Cardia F</pubmed_authors><pubmed_authors>Morais Silva P</pubmed_authors><pubmed_authors>Marques JV</pubmed_authors><pubmed_authors>Fonseca JA</pubmed_authors><pubmed_authors>Vidal C</pubmed_authors><pubmed_authors>Ferreira-Magalhaes M</pubmed_authors><pubmed_authors>Santos N</pubmed_authors><pubmed_authors>da Silva S</pubmed_authors><pubmed_authors>Ferreira TM</pubmed_authors><pubmed_authors>Pereira AM</pubmed_authors><pubmed_authors>Ferreira R</pubmed_authors><pubmed_authors>Antolin-Amerigo D</pubmed_authors><pubmed_authors>Guimaraes C</pubmed_authors><pubmed_authors>Meireles P</pubmed_authors><pubmed_authors>Morete A</pubmed_authors><pubmed_authors>Pascoa R</pubmed_authors><pubmed_authors>Simoes Cunha M</pubmed_authors><pubmed_authors>Vieira C</pubmed_authors><pubmed_authors>Vasconcelos MJ</pubmed_authors><pubmed_authors>Fernandes S</pubmed_authors><pubmed_authors>Almeida R</pubmed_authors><pubmed_authors>Lopes C</pubmed_authors><pubmed_authors>Aguiar MA</pubmed_authors><pubmed_authors>Valentim B</pubmed_authors><pubmed_authors>Mourao AR</pubmed_authors><pubmed_authors>Carvalho J</pubmed_authors><pubmed_authors>Jacome C</pubmed_authors><pubmed_authors>Coelho DS</pubmed_authors><pubmed_authors>Ribeiro C</pubmed_authors><pubmed_authors>Reis B</pubmed_authors><pubmed_authors>Bordalo D</pubmed_authors><pubmed_authors>Nunes C</pubmed_authors><pubmed_authors>Lozoya C</pubmed_authors><pubmed_authors>Alves A</pubmed_authors><pubmed_authors>Calix MJ</pubmed_authors><pubmed_authors>Monteiro R</pubmed_authors><pubmed_authors>Amaral R</pubmed_authors><pubmed_authors>Pinto D</pubmed_authors><pubmed_authors>Monteiro L</pubmed_authors><pubmed_authors>Cepa M</pubmed_authors><pubmed_authors>Marques ML</pubmed_authors><pubmed_authors>Loureiro CC</pubmed_authors><pubmed_authors>Taborda-Barata L</pubmed_authors><pubmed_authors>Silva E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.</name><description>&lt;h4>Objectives&lt;/h4>Anxiety and depression are relevant comorbidities in asthma, but, in Portugal and Spain, data on this topic are scarce. We assessed, in patients with asthma, the frequency of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and the European Quality of Life Five Dimension Questionnaire (EQ-5D); the level of agreement between these questionnaires, and the factors associated with these symptoms.&lt;h4>Methods&lt;/h4>This is a secondary analysis of the INSPIRERS studies. A total of 614 adolescents and adults with persistent asthma (32.6±16.9 years, 64.7% female) were recruited from 30 primary care centres and 32 allergy, pulmonology and paediatric clinics. Demographic and clinical characteristics, HADS and EQ-5D were collected. A score ≥8 on Hospital A</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-18T15:13:38.622Z</modification><creation>2025-04-07T01:46:50.667Z</creation></dates><accession>S-EPMC10163458</accession><cross_references><pubmed>37147092</pubmed><doi>10.1136/bmjopen-2022-068725</doi></cross_references></HashMap>